May 3 (Reuters) - Catalent ( CTLT ) and parent of Wegovy
producer Novo Nordisk have received a request for
additional information from the U.S. Federal Trade Commission
related to their merger.
In February, Novo Holdings had agreed to buy Catalent ( CTLT ) for
$16.5 billion to boost Wegovy supply.